baber/WOPTO huggingface dataset:
Patent NZ-568151-A (NZ)
Title: Discharge valve for a flushing cistern
Inventor: MAHLER ALFRED
Filed: 2008-05-09
Abstract: A discharge valve for a flushing cistern is disclosed, including: a valve housing which has an outlet opening with a valve seat; a closure body which interacts with the valve seat at a bottom end; a two-quantity actuator which has a connecting rod which is connected to the closure body and by means of which the closure body can optionally be raised by different displacement distances; a top activatable partial-quantity float for partial flushing; and a bottom, full-quantity float which is mounted in a pivotable manner on the valve housing and is intended for full flushing, which full-quantity float has a blocking element which, once partial flushing has been triggered, engages with the closure body and blocks the latter against further displacement, characterized in that the connecting rod blocks the full-quantity float in a predetermined pivoting position once partial-quantity flushing has been triggered.
Patent NZ-570494-A (NZ)
Title: Malate salts, and polymorphs of (3S,5S)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
Inventor: REDMAN-FUREY NANCY LEE
IPC: A61K31/47
Filed: 2007-03-26
Abstract: Disclosed is a malate salt of (3S,5S)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid. Also disclosed is a D,L-malate hemi-hydrate polymorphic salt of the above compound. Further disclosed is the use of a malate salt as defined above in the manufacture of a medicament for use in the treatment or prevention of an infectious disorder in a human or other animal in need of such treatment.
Patent NZ-572586-A (NZ)
Title: Substituted 5-phenylamino-1,3,4-oxadiazol-2-ylcarbonylamino-4-phenoxy-cyclohexane carboxylic acid as inhibitors of acetyl coenzyme a diacylglycerol acyltransferase
Inventor: PLOWRIGHT ALLEYN THOMAS
IPC: A61K31/4245
Filed: 2007-05-29
Abstract: Disclosed are 5-phenylamino-1,3,4-oxadiazol-2-ylcarbonylamino-4-phenoxy-cyclohexane carboxylic acid compounds of formula (I) or a salt therof wherein the substituents are as defined in the specification, a process for preparing said compounds, and their use in inhibiting acetyl CoA (acetyl coenzyme A):diacylglycerol acyl transferase (DGAT1) and treating diabetes mellitus and or obesity.
Patent NZ-579834-A (NZ)
Title: Heterocyclic compounds as selective inhibitors of PI3K activity
Inventor: CHEN YI
IPC: A61P35/00
Filed: 2008-03-24
Abstract: Disclosed are phosphatidylinositol 3-kinase (PI3K) inhibitor compounds having the depicted formula, salts thereof, and methods for their preparation. Specific examples of the compounds include (3S)-3-(8-chloro-2-(2-chlorophenyl)-3-quinolinyl)-3-(9H-purin-6-ylamino)-1-propanol, 1-(8-chloro-3-((9H-purin-6-ylamino)methyl)-2-quinolinyl)-3-piperidinol, 2-(3-fluorophenyl)-3-((1S)-1-(9H-purin-6-ylamino)ethyl)-8-quinolinecarbonitrile, and 2-(3-fluorophenyl)-3-((9H-purin-6-ylamino)methyl)-8-quinolinecarbonitrile Also disclosed is the use of the PI3K inhibitor compounds for treating cancer, rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, psoriatic arthritis, psoriasis, inflammatory diseases and autoimmune diseases, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, skin complaints with inflammatory components, chronic inflammatory conditions, autoimmune diseases, systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions and hypersensitivity.
Patent NZ-582124-A (NZ)
Title: Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents
Inventor: BHAT LAXMINARAYAN
IPC: A61K31/497
Filed: 2008-05-21
Abstract: Disclosed is a tetrahydroquinoline compound of formula II, III, IV, V, or VI and pharmaceutical compositions comprising the compounds where the substituents are as in the specification. Examples of compounds are Ethyl 4-(2-(4-( 4-(2-oxo-1 ,2,3,4-tetrahydroquinolin-7-yloxy)butyl)piperazin-1-yl)phenoxy)butanoat hydrochloride; N-(3-( 4-(2-methoxyphenyl)piperazin-1-yl)propyl)-2-oxo-1,2,3,4-tetrahydroquinoline-7 -carboxamide; and (2-oxo-1,2,3,4-tetrahydroquinolin-7-yl)methyl 3-(4-(2-methoxyphenyl)piperazin-1-yl)propanoate hydrochloride. Also disclosed is the use of the compounds for the manufacture of a medicament for treating psychoses, schizophrenia, acute manic, bipolar disorder, autistic disorder and depression.
Patent NZ-582879-A (NZ)
Title: Process for preparing 5-fluoro-1h-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof
Inventor: JIMENEZ JUAN-MIGUEL
IPC: C07D471/04
Filed: 2008-07-31
Abstract: Disclosed is a process for preparing a compound of formula I (i.e., 5-fluoro-1H-pyrazolo[3,4-b]pyridin-3-amine) comprising the step of synthesising a compound of formula 5 and combining said compound with a compound of formula 6, wherein the substituents are as described within the specification. Also disclosed is a process for preparing a compound of formula 5, and the compounds of formula I and formula 5 when prepared by said processes.
Patent NZ-587941-A (NZ)
Title: Methods to inhibit tumor cell growth by using lansoprazole
Inventor: DAMAJ BASSAM
IPC: A61K9/20
Filed: 2008-03-04
Abstract: Disclosed is the use of a pharmaceutically acceptable composition comprising an effective amount of lansoprazole or a pharmaceutically acceptable salt thereof for the preparation of a medicament for use in the treatment of cancer wherein the lansoprazole is formulated for administration at a dose of about 120mg to about 400 mg per day or about 10 mg/kg to about 100 mg/kg.
Patent NZ-590601-A (NZ)
Title: Pyrimidine compounds especially 4-phenylamino-2-arylamino-pyrimidine derivatives and compositions as protein kinase inhibitors
Inventor: MICHELLYS PIERRE-YVES
IPC: C07D239/48
Filed: 2007-11-20
Abstract: Disclosed is are 4-phenylamino-2-arylamino-pyrimidine compounds of formula 1 where R1 and R2 together form an optionally substituted 5-6 membered aryl, heteroaryl or heterocyclis ring comprising 1-3 nitrogen atoms. The rest of the substituents are as described in the specification. Also disclosed is a pharmaceutical composition containing a compound of formula 1; a combination containing a compound of formula 2 and a chemotherapeutic agent and the use of a compound of formula 2 for producing a medicament for treating a condition mediated by anaplastic lymphoma kinase, and optionally the medicament is formulated for combination with a second therapeutic agent, wherein said condition is an autoimmune disease, a transplantation disease, an infectious disease, a cell proliferative disorder; and optionally the medicament is formulated for combination with a second therapeutic agent, wherein said cell proliferative disorder is lymphoma, osteosarcoma, melanoma, non-small cell lung carcinoma, neuroblastoma or a tumour selected from breast, renal, prostate, colorectal, thyroid, ovarian, pancreatic, neuronal, lung, uterine and gastrointestinal tumour.
Patent NZ-591951-A (NZ)
Title: New amide compounds as boosters of antivirals
Inventor: HALLENBERGER BEATE SABINE
IPC: C07D277/24
Filed: 2009-10-07
Abstract: Disclosed is a carbomyl ester of formula (I) where the substituents are as disclosed in the specification and an example of compounds of formula (I) is 1S-2R-{ 1-Benzyl-2-hydroxy-3-[isobutyl-(quinoxaline-2-carbonyl)-amino]-propyl} -carbamic acid thiazol-5-ylmethyl ester. The compound is useful for enhancing the bioavailability of viral inhibitors especially HIV inhibitors. Also disclosed is a combination of a compound of formula (I) and an HIV viral inhibitor; the use of the compound or combination in the manufacture of a medicament for treating HIV; and a pharmaceutical composition comprising a compound of formula (I).
Patent NZ-595484-A (NZ)
Title: Method of treating hepatocellular carcinoma
Inventor: BERGER WALTER
IPC: A61K33/243
Filed: 2010-04-19
Abstract: 595484 Discloses the use of sodium salt of trans[tetrachlorobis(1Hindazole)ruthenate(III)] in the manufacture of a medicament for treating, preventing or delaying the onset of hepatocellular carcinoma (liver cancer)
Patent NZ-596305-A (NZ)
Title: A web-based method of identifying and collecting rental vehicle related fines from a lessee
Inventor: ULRICH JON DAVID
IPC: G06F17/30
Filed: 2011-11-09
Abstract: A method of collecting rental vehicle related fines from a lessee is disclosed. The method includes the steps of: (a) providing a main database of outstanding vehicle related fines where searchable fields of the main database include a registration number of the vehicle involved and a date when the fine was incurred, wherein the data contained in the main database is derived from data provided by a first party user; (b) providing a rental vehicle operator with a second party user ID enabling access to the main database; (c) using the second party user ID to access the main database and to search for outstanding fines relating to the registration number of a rental vehicle within a specified time period; (d) providing the rental vehicle operator with a record of any outstanding fines relating to the registration number of the rental vehicle during the specified time period; and (e) if there are recorded outstanding fines, collecting the recorded fines from the lessee.
Patent NZ-596339-A (NZ)
Title: Use of monochlorourea to treat industrial waters
Inventor: JERUSIK RUSSELL J
IPC: A01N25/02
Filed: 2010-06-25
Abstract: 596339 Disclosed herein is a method for controlling (e.g. inhibiting) or killing microorganisms in an aqueous environment. The method includes the addition of an effective amount of monochlorourea or modified monochlorourea, such as N-chloro-N,N’-dimethylurea or N-chloro-N,N’-dimethylurea, to an aqueous solution. This aqueous solution may be a cooling water system, a recreational water system, a water treatment facility, or any circulating water system (i.e. a papermaking facility). A method of producing monochlorourea or modified monochlorourea is also disclosed.
Patent NZ-607456-A (NZ)
Title: Non-luer connectors
Inventor: JIN YUN
IPC: F16L37/26
Filed: 2011-08-17
Abstract: Disclosed is a drug delivery device connector (400) for connection to a second connector. The connector comprises a container (410) having an open distal end. The open distal end includes a distal wall (418) and a sidewall including an inside surface which defines a fluid chamber for retaining fluids. An elongate tip (432) extends in a distal direction from the distal wall (418). The elongate tip (432) includes an opening which provides access to the chamber, an outside surface and a distal end. The outside surface includes an outer cross-section dimension of 0.1545 inches or less. The elongate tip (432) has a length in the range from 0.300 inches to above 0.500 inches measured from a distal end of the tip (432) to the distal wall (418).
Patent NZ-608445-A (NZ)
Title: Programmable multimedia control system having a tactile remote control
Inventor: SILVA MICHAEL C
IPC: H04N21/436
Filed: 2011-09-22
Abstract: 608445 Disclosed is an expandable multimedia control system having two wireless communication paths and a remote control extension for a portable communication device. The system is comprised of a programmable multimedia controller, a dedicated wireless receiver, a portable communication device and a remote control device. The programmable multimedia controller includes a general purpose computer executing one or more applications. The programmable multimedia controller is configured for controlling, switching data among and interconnecting associated components including one or more of audio, video, telephony, data, security, motor-driven or relay driven parts so as to provide one or more programmable services. The portable communication device is in communicative relationship with the programmable multimedia controller, by way of a bi-directional wireless communication path, and further in communicating relationship with the dedicated wireless receiver to provide a redundant communication path. The remote control device is configured to slidingly receive the portable communication device into a recess such that the portable communication device is mechanically and electrically coupled to the remote control. The remote control includes surface-enhanced buttons allowing a user to make selections by the sense of touch for selecting setting of associated components.
Patent NZ-610282-A (NZ)
Title: Optimized nutritional formulations, methods for selection of tailored diets therefrom, and methods of use thereof
Inventor: BHAGAT URVASHI
IPC: G16H10/60
Filed: 2011-10-14
Abstract: Disclosed is a formulation, comprising a source of phytochemical comprising one or more polyphenols, a source of omega-6 fatty acids, and a source of antioxidant; wherein the formulation provides a dosage of 1 to 40g of omega-6 fatty acids, a dosage of 25mg-10g of antioxidants, and a dosage of greater than 5mg of polyphenols. Further disclosed is a method of providing nutrition to an individual, the method comprising the steps of: (a) determining for the individual a diet cohort based on dietary preferences and/or a demographic factor; and (b) on the basis of the diet cohort selecting one or more nutritional formulations for the individual, which include at least one formulation comprising a source of phytochemical, a source of omega-6 fatty acid, and a source of antioxidant; wherein the one or more formulations collectively provide a daily dosage of 1 to 40g of omega-6 fatty acids, 25mg-10g of antioxidants, and one or more phytochemicals comprising one or more polyphenols which provide a daily dosage greater than 5mg of polyphenols; and (c) providing the one or more formulations to the individual, wherein the method is not a method of medical treatment or a method of medical prophylaxis.
Patent NZ-610559-A (NZ)
Title: Sensor for acquiring physiological signals
Inventor: MACIÁ BARBER AGUSTIN
IPC: A61B5/296
Filed: 2011-11-16
Abstract: A sensor to be placed in contact with the skin 12 of a user for acquiring physiological signals includes a conductive layer 2 to be placed in contact with the skin for receiving the signals, the conductive layer comprising a conductive fabric of interlaced or interwoven conductive fibres and non-conductive fibres forming a plurality of orifices throughout the conductive fabric. An electrical connector 5 is connected to the conductive layer to transfer the signals to an analysis system. The conductive layer includes the electrode portion 3 and a track portion 4 which is connected to the connector 5. To gently hold the sensor on the skin without adhesives the plurality of orifices 6 are formed in the conductive layer throughout the electrode area, with each orifice filled with silicone rubber without the use of adhesives. The silicone rubber only covers the orifice areas of the electrode. The sensor may be adhered to the cloth 7 of a garment so that the garment serves to hold the electrode against the skin of the chest of the wearer.
Patent NZ-622208-A (NZ)
Title: Kinase inhibitor polymorphs
Inventor: REN PINGDA
IPC: C07D487/04
Filed: 2012-08-10
Abstract: Provided are polymorphic forms of 5-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)benzo[d]oxazol-2-Amine and processes for their preparation. The polymorphs may be useful in the treatment of mTOR associated diseases.
Patent NZ-629668-A (NZ)
Title: Cooling system and a method for separation of oil
Inventor: LARSEN FLEMMING CLARENCE
IPC: F25B43/02
Filed: 2013-03-05
Abstract: The invention relates to a cooling system and a method for oil separation, where a condenser unit (10) contains oil separators (18,20), from which oil in oil separators is lead through a pipeline (24) and back to the compressor unit (10). The system can perform condensing functions and oil separation functions into a common pressure container (26). The condenser unit (10) and oil separators (18, 20) are integrated in a common pressure container (26) that contains at least one first oil separator (18) and at least a second secondary oil separator (20), which the pressure container (26) contains a condenser container (30) which interacts with a third oil separator (22).
Patent NZ-704576-A (NZ)
Title: Systems and methods for monitoring a flow path
Inventor: FREESE ROBERT P
IPC: G01N21/17
Filed: 2013-09-10
Abstract: Disclosed are systems and methods for analyzing a flow of a fluid at two or more discrete locations to determine the concentration of a substance therein. One method of determining a characteristic of a fluid may include containing a fluid within a flow path that provides at least a first monitoring location and a second monitoring location, generating a first output signal corresponding to the characteristic of the fluid at the first monitoring location with a first optical computing device, generating a second output signal corresponding to the characteristic of the fluid at the second monitoring location with a second optical computing device, receiving first and second output signals from the first and second optical computing devices, respectively, with a signal processor, and determining a difference between the first and second output signals with the signal processor wherein at least one of the first or second integrated computational elements comprises a plurality of alternating layers of two different materials, the two different materials are selected from the group consisting of silicon, silica (SiO2), quartz, niobia, niobium, germanium, germania, and magnesium fluoride, a thickness of each of the plurality of alternating layers is selected according to a spectral attribute of the characteristic of the fluid, and a portion of the optically interacted light is transmitted through the at least one of the first or second integrated computational elements. .
Patent NZ-708033-A (NZ)
Title: Anti-blood dendritic cell antigen 2 antibodies and uses thereof
Inventor: CARAVELLA JUSTIN A
IPC: C07K16/28
Filed: 2013-12-10
Abstract: Antibodies and antibody fragments that bind to BDCA2 are disclosed. Also disclosed are methods of using the antibodies and antibody fragments to induce death of a plasmacytoid dendritic cell, inhibit production or secretion of inflammatory cytokines and chemokines, and treat or prevent immunological disorders such as inflammatory and autoimmune conditions.
Patent NZ-718540-A (NZ)
Title: Control for pressure of a patient interface
Inventor: HOLLEY LIAM
IPC: A61M16/00
Filed: 2014-10-28
Abstract: A method of an apparatus control pressure in the patient interface. A vent valve may be used with a respiratory device, where the vent valve may selectively block fluid communication between components, such as the flow generator, the patient interface, and/or the vent. An expiratory flow model may be used to determine an expiratory characteristic such as an expiratory flow rate or pressure in the patient interface where an indicative measure may not be available. The expiratory flow model may receive inputs based on a measure of the patient’s respiration, such as the tidal volume, peak inspiratory flow rate or length of inspiration. The expiratory characteristic may be used by a controller to control a pressure in the patient interface to provide respiratory therapy to a patient at or close to a target pressure.
Patent NZ-718807-A (NZ)
Title: Soil opener
Inventor: GENT ANTHONY
IPC: A01C7/20
Filed: 2014-11-11
Abstract: A soil opener comprises first and second soil-cutting members (20,1). The first member (20) has a first soil-engaging surface (20”) inclined at a first angle (H) to a perpendicular (V) to the soil surface (G) when viewed along a travel direction, the first angle (H) being greater than zero, and at a second angle (J) to the travel direction when viewed along a perpendicular (V), the second angle (J) being greater than zero. The second member comprises a rotating disc (1) and has a second soil-engaging surface (1”) that faces away from, and in a substantially opposite direction to, the first soil-engaging surface (20”), the second soil-engaging surface (1”) being inclined at a third angle (F) to a perpendicular (V) when viewed along the travel direction, the third angle (F) being greater than zero and in the same sense as said first angle (H).
Patent NZ-727028-A (NZ)
Title: Compositions and methods for lowering triglycerides without raising ldl-c levels
Inventor: MANKU MEHAR
IPC: C12P7/64
Filed: 2010-06-15
Abstract: Disclosed is the use of ethyl eicosapentaenoate in the manufacture of a medicament for treating or preventing cardiovascular disease by increasing plasma and/or serum EPA by in a subject having a baseline plasma and/or serum EPA level of not more than about 50ug/ml, wherein the medicament comprises at least 96%, by weight, ethyl eicosapentaenoate, about 0.2% to about 0.5% by weight ethyl octadecatetraenoate, about 0.05% to about 0.25% by weight ethyl nonadecapentaenoate, about 0.2% to about 0.45% by weight ethyl arachidonate, about 0.3% to about 0.5% by weight ethyl eicosatetraenoate, about 0.05% to about 0.32% ethyl heneicosapentaenoate and not more than 0.05% ethyl-DHA, if any, wherein the dose to be administered is 2g to 4g for a time period of at least 6 weeks, wherein the subject exhibits an increase of at least about 200% in plasma and/or serum EPA compared to baseline.
Patent NZ-727083-A (NZ)
Title: Positioning and stabilising structure for a patient interface system
Inventor: DUNN JESSICA
IPC: A61M16/06
Filed: 2013-11-15
Abstract: A patient interface system to treat sleep disordered breathing of a patient with pressurized gas, comprising: a patient interface (3000); at least one strap (3308); at least one cushion (3310) structured to at least partially conform to the patient’s head; and at least one retractor (3304) fixedly attached to said at least one cushion. The at least one retractor is connected to the at least one strap and configured to retract the at least one strap without patient actuation to urge the patient interface toward the patient’s face. The at least one strap joins the at least one retractor to the patient interface.
Patent NZ-730560-A (NZ)
Title: Control system for control of distribution of medication
Inventor: STEWART RICHARD ALISTAIR BALFOUR
IPC: G16H20/70
Filed: 2015-09-28
Abstract: A system of controlling distribution of a medication in the treatment or prevention of epilepsy is provided. A central controller of the system has a data store and one or more processors for reading and writing data to the data store. The data store comprises a database of patient records, each patient record having a medication authorization field. The central controller can output an authorization of a first prescription of epilepsy medication to a patient in dependence upon genetic test results for the patient and schedules a subsequent test for the patient prior to authorization of a subsequent prescription of epilepsy medication. Also provided are methods in which the subject systems find use. The systems and methods find use in the treatment of severe subtypes of epilepsy or refractory epilepsy, such as Dravet Syndrome.